Health Economics, Janssen Pharmaceutical KK, Tokyo, Japan.
Center of Pharmaceutical Outcomes Research, Naresuan University, Phitsanulok, Thailand.
Influenza Other Respir Viruses. 2017 Nov;11(6):543-555. doi: 10.1111/irv.12505. Epub 2017 Oct 27.
Little is known about the economic burden of influenza-related hospitalizations in Japan. This study sought to identify the factors that contribute to the total healthcare costs (THCs) associated with hospitalizations due to influenza in the Japanese population.
A retrospective cross-sectional database analysis study.
A structural equation modelling approach was used to analyse a nationwide Japanese hospital claims data. This study included inpatients with at least 1 confirmed diagnosis of influenza and with a hospital stay of at least 2 days, who were admitted between April 2014 and March 2015.
A total of 5261 Japanese inpatients with a diagnosis of influenza were included in the final analysis. The elderly (≥65 years) and the young (≤15 years) comprised more than 85% of patients. The average length of stay (LOS) was 12.5 days, and the mean THC was 5402 US dollars (US$) per hospitalization. One additional hospital day increased the THC by 314 US$. Intensive care unit hospitalizations were linked to higher costs (+4957 US$) compared to regular hospitalizations. The biggest procedure-related cost drivers, which were also impacted by LOS, were blood transfusions (+6477 US$), tube feedings (+3501 US$) and dialysis (+2992 US$).
In Japan, the economic burden due to influenza-related hospitalizations for both children and the elderly is considerable and is further impacted by associated comorbidities, diagnostic tests and procedures that prolong the LOS.
关于流感相关住院治疗在日本造成的经济负担,人们知之甚少。本研究旨在确定导致日本人群因流感住院相关总医疗成本(THC)的因素。
回顾性横截面数据库分析研究。
采用结构方程模型方法对全国性日本医院索赔数据进行分析。本研究纳入了至少有 1 次确诊流感且住院时间至少 2 天的住院患者,这些患者于 2014 年 4 月至 2015 年 3 月期间入院。
共有 5261 例日本流感住院患者纳入最终分析。患者中老年人(≥65 岁)和年轻人(≤15 岁)占比超过 85%。平均住院时间(LOS)为 12.5 天,每次住院的平均 THC 为 5402 美元。每增加 1 天住院时间,THC 增加 314 美元。与普通住院相比,重症监护病房住院的费用更高(+4957 美元)。与 LOS 相关的最大的与治疗相关的成本驱动因素包括输血(+6477 美元)、管饲(+3501 美元)和透析(+2992 美元)。
在日本,儿童和老年人因流感相关住院治疗造成的经济负担相当大,并且会受到相关合并症、诊断测试和延长 LOS 的治疗的影响。